REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,941,000 | -18.4% | 29,496 | +1.1% | 0.01% | -30.0% |
| Q4 2020 | $3,605,000 | +155.1% | 29,163 | +101.1% | 0.01% | +150.0% |
| Q3 2020 | $1,413,000 | +447.7% | 14,499 | +15.2% | 0.00% | +300.0% |
| Q1 2018 | $258,000 | -27.7% | 12,591 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $357,000 | -8.9% | 12,591 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $392,000 | -1.5% | 12,591 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $398,000 | +39.6% | 12,591 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $285,000 | – | 12,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |